In a Geneva conference room buzzing with quiet determination, delegates at the Seventy-ninth World Health Assembly took decisive steps toward turning the tide on three silent global health crises: tuberculosis, steatotic liver disease, and bleeding disorders. While TB has claimed more lives annually than any other infectious disease for years, the Assembly’s endorsement of a post-2030 strategy signals a renewed commitment to ending it once and for all. Between 2000 and 2024, expanded treatment saved an estimated 83 million lives—a monumental achievement—but progress has stalled, with global targets still off track due to underfunding, inequality, and climate-related displacement. The new strategy, to be presented in 2028, will harness emerging science and align with universal health coverage and global health security, paving the way for the next UN High-Level Meeting on TB.

Equally urgent is the rising burden of steatotic liver disease (SLD), newly recognized by the Assembly as a critical noncommunicable disease. Affecting 1.7 billion people worldwide, SLD—once known as fatty liver disease—is now one of the fastest-growing causes of chronic liver disease. Driven by obesity, type 2 diabetes, and unhealthy lifestyles, it can progress to cirrhosis and liver cancer if left unaddressed. The resolution urges countries to integrate SLD into national health plans, strengthen early detection, and act across sectors to combat shared risk factors like poor diets and alcohol use. WHO will now support countries with technical guidance and report every two years on progress—marking a pivotal shift in how the world addresses metabolic health.

Meanwhile, for the nearly 70% of people with haemophilia who remain undiagnosed, the Assembly’s resolution is more than policy—it’s hope. Haemophilia and other bleeding disorders cause debilitating and life-threatening bleeding, yet have long been neglected in global health agendas. This landmark decision calls for integrating care into national NCD and maternal health strategies, expanding access to life-saving treatments like factor concentrates, and including novel therapies in Essential Medicines Lists. Countries also pledged to improve diagnosis, reduce stigma, and ensure timely referrals to specialized centers—steps that could transform lives, especially for children and adolescents.

Together, these resolutions reflect a broader shift: from reactive care to proactive, equitable health systems that leave no one behind. They acknowledge that behind every statistic is a person waiting for a diagnosis, a treatment, or a chance. As the world prepares for 2030 and beyond, the path forward is clear—not just to treat disease, but to build resilience, equity, and dignity into the foundation of global health.